Literature DB >> 26617924

A case of gastric cancer with heterogeneous components of EB virus (+)/TP53 (+) and EB virus (-)/TP53 (-).

Ikuo Matsuda1, Kazuomi Kan2, Sadayuki Doi2, Yoshiyuki Motoki2, Masayuki Onodera3, Seiichi Hirota1.   

Abstract

Epstein-Barr virus (EBV)-associated gastric adenocarcinoma is a histological subtype of gastric adenocarcinoma, in which all of the carcinoma cells are basically positive for EBV-encoded small RNA (EBER) by in situ hybridization. Although its typical histology has some overlap with gastric carcinoma with lymphoid stroma, absence of massive lymphoid infiltrate is sometimes observed either in whole or in part. EBV-associated adenocarcinoma is one of the four representative molecular pathological subtypes recently identified by comprehensive genomic analysis of gastric adenocarcinomas. According to the analysis, typical EBV-associated gastric adenocarcinoma constitutes an independent molecular pathological subgroup, which is mutually exclusive to TP53-mutated adenocarcinoma with chromosomal instability, another molecular pathological subtype in gastric adenocarcinomas. Here, we report a rare case of gastric cancer heterogeneously composed of EBER (+)/TP53 (+) and EBER (-)/TP53 (-) portions. The EBER (+)/TP53 (+) component with massive lymphoid infiltrate surrounded the EBER (-)/TP53 (-) component showing well to moderately differentiated tubular adenocarcinoma. Although collision of two independent gastric cancers could be the simplest and most possible explanation for this situation, we discussed another possibility. In the case of gastric collision tumors, concurrent development of EBER (+) gastric adenocarcinomas and EBER (-) gastric adenocarcinomas in a single stomach is a rare incident. Since presence of the EBER (+)/TP53 (+) tumor component is atypical in itself, we also discussed the mechanism of development of the clone.

Entities:  

Keywords:  Epstein-Barr virus; Gastric adenocarcinoma; TP53; adenocarcinoma with lymphoid stroma; collision tumor

Mesh:

Substances:

Year:  2015        PMID: 26617924      PMCID: PMC4637740     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  18 in total

Review 1.  Update on Epstein-Barr virus and gastric cancer (review).

Authors:  Aya Shinozaki-Ushiku; Akiko Kunita; Masashi Fukayama
Journal:  Int J Oncol       Date:  2015-01-28       Impact factor: 5.650

2.  p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma.

Authors:  Tetsuo Ushiku; Ja-Mun Chong; Hiroshi Uozaki; Rumi Hino; Moon-Sung Chang; Makoto Sudo; Barua Rita Rani; Kazuya Sakuma; Hideo Nagai; Masashi Fukayama
Journal:  Int J Cancer       Date:  2007-01-01       Impact factor: 7.396

3.  Different roles of p53 between Epstein-Barr virus-positive and -negative gastric carcinomas of matched histology.

Authors:  Suzuko Moritani; Hiroyuki Sugihara; Ryoji Kushima; Takanori Hattori
Journal:  Virchows Arch       Date:  2001-11-23       Impact factor: 4.064

4.  p53 overexpression is different in Epstein-Barr virus-associated and Epstein-Barr virus-negative carcinoma.

Authors:  S Y Leung; K Y Chau; S T Yuen; K M Chu; F J Branicki; L P Chung
Journal:  Histopathology       Date:  1998-10       Impact factor: 5.087

Review 5.  Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma.

Authors:  Chaturika Harshini Pavithra Herath; Runjan Chetty
Journal:  Arch Pathol Lab Med       Date:  2008-04       Impact factor: 5.534

6.  Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan.

Authors:  H Matsunou; F Konishi; H Hori; T Ikeda; K Sasaki; Y Hirose; N Yamamichi
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

7.  H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression.

Authors:  Valeska Portela Lima; Marcos Antonio Pereira de Lima; Angela Rosa André; Márcia Valéria Pitombeira Ferreira; Marcos Aurélio Pessoa Barros; Sílvia Helena Barem Rabenhorst
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

Review 8.  Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis.

Authors:  Ju-Han Lee; Seo-Hee Kim; Sun-Hee Han; Jung-Suk An; Eung-Seok Lee; Young-Sik Kim
Journal:  J Gastroenterol Hepatol       Date:  2009-03       Impact factor: 4.029

Review 9.  The AID/APOBEC family of nucleic acid mutators.

Authors:  Silvestro G Conticello
Journal:  Genome Biol       Date:  2008-06-17       Impact factor: 13.583

10.  Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas.

Authors:  H Ojima; T Fukuda; T Nakajima; Y Nagamachi
Journal:  Jpn J Cancer Res       Date:  1997-03
View more
  3 in total

1.  Diagnosis and clinical implication of collision gastric adenocarcinomas: a case report.

Authors:  Hiromitsu Imataki; Hideo Miyake; Hidemasa Nagai; Yuichiro Yoshioka; Norihiro Yuasa; Junichi Takamizawa; Ayami Kiriyama; Masahiko Fujino
Journal:  Surg Case Rep       Date:  2022-10-07

2.  Collision of Epstein-Barr virus-positive and -negative gastric cancer, diagnosed by molecular analysis: a case report.

Authors:  Ken Miyabe; Motonobu Saito; Kei Koyama; Michinobu Umakoshi; Yukinobu Ito; Makoto Yoshida; Yukitsugu Kudo-Asabe; Katsuharu Saito; Hiroshi Nanjo; Daichi Maeda; Keisuke Matsusaka; Akiteru Goto; Koji Kono
Journal:  BMC Gastroenterol       Date:  2021-03-02       Impact factor: 3.067

3.  A Rare Case of Moderately Differentiated Adenocarcinoma With PD-L1 Overexpression and a Heterogeneous LELC Component in the Ascending Colon.

Authors:  Hideki Nagano; Takeshi Watanabe; Tamotsu Togawa; Kenji Ohnishi; Toshihisa Kimura; Atsushi Iida; Yasunori Sato; Takanori Goi
Journal:  Onco Targets Ther       Date:  2020-01-28       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.